These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28485025)

  • 1. Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokines.
    Beltrán B; Sáez-González E; Moret I; Díaz-Jaime FC; Alvarez-Sotomayor D; Cerrillo E; Iborra M; Bastida G; Aguas M; Nos P
    J Clin Apher; 2018 Feb; 33(1):99-103. PubMed ID: 28485025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders.
    Sacco R; Tanaka T; Yamamoto T; Bresci G; Saniabadi AR
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):327-33. PubMed ID: 25160857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.
    Schultheiß C; Weischenberg R; Herrmann A; Haller B; Schmid RM; Reindl W; Huber W
    Artif Organs; 2015 Feb; 39(2):187-92. PubMed ID: 24981894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China.
    Lai YM; Yao WY; He Y; Jiang X; Gu YB; Chen MH; Liu YL; Yuan YZ; Qian JM
    Gut Liver; 2017 Mar; 11(2):216-225. PubMed ID: 27843131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
    Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis.
    Toya Y; Chiba T; Mizutani T; Sato K; Kasugai S; Matsuda N; Orikasa S; Shibata S; Abiko Y; Akasaka R; Yokoyama N; Oana S; Hirota S; Endo M; Suzuki K
    Cytokine; 2013 Apr; 62(1):146-50. PubMed ID: 23465691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.
    Dignass A; Akbar A; Baumgart DC; Bommelaer G; Bouguen G; Cadiot G; Gillessen A; Grimaud JC; Hart A; Hoque S; Makins R; Michiels C; Moreau J; Premchand P; Ramlow W; Schanz S; Subramanian S; von Tirpitz C; Bonaz B
    Scand J Gastroenterol; 2018 Apr; 53(4):442-448. PubMed ID: 29513111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapy.
    Sagawa T; Kakizaki S; Tomizawa T; Nakayama T; Tanaka H; Tojima H; Sato K; Kusano M; Okamura S; Yamada M
    Colorectal Dis; 2016 Jul; 18(7):696-702. PubMed ID: 26748553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
    Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
    Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis.
    Yanagisawa K; Murakami M; Kondo Y; Oguma S; Kobayashi S; Miyasaka H; Shinohara T; Tomori A; Nakano Y; Furuhata S; Ikezoe M
    Ther Apher Dial; 2019 Jun; 23(3):217-223. PubMed ID: 31025815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcerative colitis and granulocyte-monocyte-apheresis: safety and efficacy of maintenance therapy during pregnancy.
    D'Ovidio V; Meo D; Gozer M; Bazuro ME; Vernia P
    J Clin Apher; 2015 Feb; 30(1):55-7. PubMed ID: 25181523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
    Yamamoto T; Umegae S; Matsumoto K
    J Crohns Colitis; 2012 Aug; 6(7):750-5. PubMed ID: 22398094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
    Yokoyama Y; Watanabe K; Ito H; Nishishita M; Sawada K; Okuyama Y; Okazaki K; Fujii H; Nakase H; Masuda T; Fukunaga K; Andoh A; Nakamura S
    Cytotherapy; 2015 May; 17(5):680-8. PubMed ID: 25804800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA and granulocyte-monocyte adsorption apheresis combotherapy after inadequate response to anti-TNF agents in ulcerative colitis.
    Sáez-González E; Moret-Tatay I; Bastida G; Aguas M; Iborra M; Nos P; Beltrán B
    J Clin Apher; 2024 Feb; 39(1):e22101. PubMed ID: 38054256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study.
    Yamamoto T; Umegae S; Matsumoto K
    J Gastroenterol; 2011 Aug; 46(8):1003-9. PubMed ID: 21681409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of granulocyte-monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?
    Rodríguez-Lago I; Benítez JM; Sempere L; Sáez-González E; Barreiro-de Acosta M; de Zárate JO; Cabriada JL
    J Clin Apher; 2019 Dec; 34(6):680-685. PubMed ID: 31518013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of adsorptive granulomonocytapheresis in Chinese patients with ulcerative colitis: A retrospective analysis of 50 cases with focus on factors impacting clinical efficacy.
    Li N; Mao J; Tang H; Zhu L; Tan X; Bi J; Wu H; Chen X; Wang Y
    J Clin Apher; 2020 Aug; 35(4):271-280. PubMed ID: 32378240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.
    Saniabadi AR; Tanaka T; Ohmori T; Sawada K; Yamamoto T; Hanai H
    World J Gastroenterol; 2014 Aug; 20(29):9699-715. PubMed ID: 25110409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.